{"altmetric_id":6722048,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":7},"twitter":{"unique_users_count":4,"unique_users":["mtmdphd","OncoTherapyNet","colmant_","bhemato"],"posts_count":7}},"citation":{"altmetric_jid":"4f6fa52c3cf058f610004086","authors":["Mattia D\u2019Agostino","Antonio Palumbo"],"doi":"10.1200\/jop.2016.011627","endpage":"294","first_seen_on":"2016-04-14T19:25:29+00:00","funders":["niehs"],"issns":["1935-469X"],"issue":"4","journal":"Journal of Oncology Practice","last_mentioned_on":1501095919,"links":["http:\/\/jop.ascopubs.org\/content\/12\/4\/293.extract"],"pdf_url":"http:\/\/jop.ascopubs.org\/content\/12\/4\/293.full.pdf","pmid":"27072381","pubdate":"2016-04-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences","Nursing"],"startpage":"293","subjects":["neoplasms"],"title":"Moving Toward a Tailored Therapy in Multiple Myeloma","type":"article","volume":"12","mendeley_url":"http:\/\/www.mendeley.com\/research\/moving-toward-tailored-therapy-multiple-myeloma"},"altmetric_score":{"score":2.45,"score_history":{"1y":1.6,"6m":1.6,"3m":0.25,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.45},"context_for_score":{"all":{"total_number_of_other_articles":8277330,"mean":6.982694453965,"rank":3427352,"this_scored_higher_than_pct":58,"this_scored_higher_than":4842067,"rank_type":"exact","sample_size":8277330,"percentile":58},"similar_age_3m":{"total_number_of_other_articles":275265,"mean":11.576175722215,"rank":103150,"this_scored_higher_than_pct":62,"this_scored_higher_than":171743,"rank_type":"exact","sample_size":275265,"percentile":62},"this_journal":{"total_number_of_other_articles":1012,"mean":10.421586547972,"rank":674,"this_scored_higher_than_pct":33,"this_scored_higher_than":336,"rank_type":"exact","sample_size":1012,"percentile":33},"similar_age_this_journal_3m":{"total_number_of_other_articles":68,"mean":6.5126865671642,"rank":47,"this_scored_higher_than_pct":30,"this_scored_higher_than":21,"rank_type":"exact","sample_size":68,"percentile":30}}},"demographics":{"poster_types":{"member_of_the_public":3,"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1,"Members of the public":3}},"mendeley":{"by_status":{"Other":1},"by_discipline":{"Medicine and Dentistry":1}}},"geo":{"twitter":{"US":3}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/720694398594478080","license":"gnip","citation_ids":[6722048],"posted_on":"2016-04-14T19:25:09+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"720694398594478080"},{"url":"http:\/\/twitter.com\/OncoTherapyNet\/statuses\/720694896701538304","license":"gnip","rt":["mtmdphd"],"citation_ids":[6722048],"posted_on":"2016-04-14T19:27:07+00:00","author":{"name":"OncoTherapy Network","url":"http:\/\/www.oncotherapynetwork.com\/http:\/\/","image":"https:\/\/pbs.twimg.com\/profile_images\/553317801734070272\/jD07wIQ__normal.png","description":"OncoTherapy Network aids clinicians in improving patient outcomes through the use of targeted therapies and immunotherapies for cancer treatment.","id_on_source":"OncoTherapyNet","tweeter_id":"2384028506","geo":{"lt":null,"ln":null},"followers":1267},"tweet_id":"720694896701538304"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/773882074004656128","license":"gnip","citation_ids":[6722048],"posted_on":"2016-09-08T13:53:59+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"773882074004656128"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/859898227147100162","license":"gnip","citation_ids":[6722048],"posted_on":"2017-05-03T22:31:28+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"859898227147100162"},{"url":"http:\/\/twitter.com\/colmant_\/statuses\/859898518009499649","license":"gnip","rt":["mtmdphd"],"citation_ids":[6722048],"posted_on":"2017-05-03T22:32:37+00:00","author":{"name":"colmant_","url":"https:\/\/twitter.com\/colmant_","image":"http:\/\/pbs.twimg.com\/profile_images\/3754459095\/1434fee7861732771777ffd34d62e01a_normal.jpeg","description":"Democrat, advocate for physically and mentally challenged individuals, enjoy cooking,reading,  thought provoking conversations.Love my Yorkie!\r\n  NC","id_on_source":"colmant_","tweeter_id":"414010452","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":2969},"tweet_id":"859898518009499649"},{"url":"http:\/\/twitter.com\/bhemato\/statuses\/859900731725410305","license":"gnip","rt":["mtmdphd"],"citation_ids":[6722048],"posted_on":"2017-05-03T22:41:25+00:00","author":{"name":"Binod Dhakal","image":"https:\/\/pbs.twimg.com\/profile_images\/506637496654901248\/bTIOp3tv_normal.jpeg","description":"MCW Faculty. Myeloma. Lymphoma and Clinical trials.","id_on_source":"bhemato","tweeter_id":"2783218747","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":280},"tweet_id":"859900731725410305"},{"url":"http:\/\/twitter.com\/mtmdphd\/statuses\/890286931162136576","license":"gnip","citation_ids":[6722048],"posted_on":"2017-07-26T19:05:19+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15274},"tweet_id":"890286931162136576"}]}}